Sonnet BioTherapeutics Holdings (SONN)
US Market

Sonnet BioTherapeutics Holdings (SONN) Balance Sheet


Sonnet BioTherapeutics Holdings Balance Sheet

Sonnet BioTherapeutics Holdings's total assets for Q1 2024 were $5.34M, a decrease of -1.69% from the previous quarter. SONN total liabilities were $2.77M for the fiscal quarter, a -51.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Assets
$ 5.43M$ 5.83M$ 28.99M$ 7.99M$ 39.75K
Total Liabilities
$ 5.66M$ 8.37M$ 6.73M$ 4.97M$ 2.89M
Total Equity Gross Minority
$ -225.98K$ -2.54M$ 22.26M$ 3.02M$ -2.85M
Total Capitalization
$ -95.12K$ -2.54M$ 22.26M$ 3.14M$ -2.85M
Preferred Stock Equity
Capital Lease Obligations
---$ 207.19K$ 0.00
Currency in USD

Sonnet BioTherapeutics Holdings Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis